CSCs exhibit several mechanisms that render them resistant to conventional chemotherapy and radiotherapy. These include efficient DNA repair systems, active drug efflux pumps, and a quiescent (dormant) state that makes them less susceptible to therapies targeting rapidly dividing cells. Histologically, this resistance can be observed as residual CSCs in post-treatment tumor samples.
